Cargando…

Zeolites as Carriers of Antitumor Ribonuclease Binase

Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by...

Descripción completa

Detalles Bibliográficos
Autores principales: Khojaewa, Vera, Lopatin, Oleg, Zelenikhin, Pavel, Ilinskaya, Olga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509225/
https://www.ncbi.nlm.nih.gov/pubmed/31130858
http://dx.doi.org/10.3389/fphar.2019.00442
_version_ 1783417205979873280
author Khojaewa, Vera
Lopatin, Oleg
Zelenikhin, Pavel
Ilinskaya, Olga
author_facet Khojaewa, Vera
Lopatin, Oleg
Zelenikhin, Pavel
Ilinskaya, Olga
author_sort Khojaewa, Vera
collection PubMed
description Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by antitumor ribonuclease binase and the cytotoxicity of the obtained complexes. We found the optimal conditions for binase loading into zeolites and established the dynamic of its release. Cytotoxic effects of zeolite-binase complexes toward colorectal cancer Caco2 cells were characterized after 24 and 48 h of incubation with cells using MTT-test. Zeolites were toxic by itselfs and reduced cells viability by 30% (clinoptilolite), 40% (chabazite), and 70% (natrolite) after 48 h of incubation. Binase complexes with clinoptilolite as well as chabazite always demonstrated enhanced toxicity (up to 57 and 60% for clinoptilolite and chabazite, respectively) in comparison with binase and zeolites separately. Our results contribute to the perspective development of binase-based complexes for therapy of colorectal cancer for or the treatment of malignant skin neoplasms where the complexes can be used in pasty form.
format Online
Article
Text
id pubmed-6509225
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65092252019-05-24 Zeolites as Carriers of Antitumor Ribonuclease Binase Khojaewa, Vera Lopatin, Oleg Zelenikhin, Pavel Ilinskaya, Olga Front Pharmacol Pharmacology Natural and synthetic zeolites have many applications in biomedicine and nutrition. Due to its properties, zeolites can absorb therapeutically active proteins and release them under physiological conditions. In this study we tested the clinoptilolite, chabazite, and natrolite ability to be loaded by antitumor ribonuclease binase and the cytotoxicity of the obtained complexes. We found the optimal conditions for binase loading into zeolites and established the dynamic of its release. Cytotoxic effects of zeolite-binase complexes toward colorectal cancer Caco2 cells were characterized after 24 and 48 h of incubation with cells using MTT-test. Zeolites were toxic by itselfs and reduced cells viability by 30% (clinoptilolite), 40% (chabazite), and 70% (natrolite) after 48 h of incubation. Binase complexes with clinoptilolite as well as chabazite always demonstrated enhanced toxicity (up to 57 and 60% for clinoptilolite and chabazite, respectively) in comparison with binase and zeolites separately. Our results contribute to the perspective development of binase-based complexes for therapy of colorectal cancer for or the treatment of malignant skin neoplasms where the complexes can be used in pasty form. Frontiers Media S.A. 2019-05-03 /pmc/articles/PMC6509225/ /pubmed/31130858 http://dx.doi.org/10.3389/fphar.2019.00442 Text en Copyright © 2019 Khojaewa, Lopatin, Zelenikhin and Ilinskaya. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Khojaewa, Vera
Lopatin, Oleg
Zelenikhin, Pavel
Ilinskaya, Olga
Zeolites as Carriers of Antitumor Ribonuclease Binase
title Zeolites as Carriers of Antitumor Ribonuclease Binase
title_full Zeolites as Carriers of Antitumor Ribonuclease Binase
title_fullStr Zeolites as Carriers of Antitumor Ribonuclease Binase
title_full_unstemmed Zeolites as Carriers of Antitumor Ribonuclease Binase
title_short Zeolites as Carriers of Antitumor Ribonuclease Binase
title_sort zeolites as carriers of antitumor ribonuclease binase
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509225/
https://www.ncbi.nlm.nih.gov/pubmed/31130858
http://dx.doi.org/10.3389/fphar.2019.00442
work_keys_str_mv AT khojaewavera zeolitesascarriersofantitumorribonucleasebinase
AT lopatinoleg zeolitesascarriersofantitumorribonucleasebinase
AT zelenikhinpavel zeolitesascarriersofantitumorribonucleasebinase
AT ilinskayaolga zeolitesascarriersofantitumorribonucleasebinase